DREAM results do not support omega-3 supplementation for dry eye disease

Penny Asbell
WASHINGTON — The results of the 1-year Dry Eye Assessment and Management trial found insufficient evidence to support patients taking oral omega-3 supplements to reduce the signs and symptoms of dry eye disease, according to a speaker here.
“This NEI-supported clinical trial shows that oral omega-3 is no better than placebo in relieving signs and symptoms of dry eye disease,” Penny Asbell, MD, study chair of the DREAM trial, said during Cornea Day at the American Society of Cataract and Refractive Surgery annual meeting.
The DREAM trial is (Read more...)

Full Story →